Search
Decyl(dimethyl)phosphine oxide
go.drugbank.com/drugs/DB07641ExperimentalCategories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesLinaprazan glurate
go.drugbank.com/drugs/DB21534Investigationalto Gastroesophageal Reflux Disease (GERD)). … Linaprazan glurate is under investigation in clinical trial NCT07037875 (A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due
Nogalamycin
go.drugbank.com/drugs/DB20882ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Nogalamycin is a antibiotic, produced by Streptomyces strain. Nogalamycin has a monoisotopic molecular weight of 787.31 Da.
Categories: Compounds used in a research, industrial, or household settingKP-1461
go.drugbank.com/drugs/DB05644InvestigationalKP-1461 is a potent, non-chain-terminating, mutagenic deoxyribonucleoside analogue. Designated a DNA covert nucleoside, the drug consists of a modified base that incorporates randomly into HIV and pairs with multiple bases.
Fulzerasib
go.drugbank.com/drugs/DB21609InvestigationalFulzerasib is under investigation in clinical trial NCT06936644 (A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab (AK- … 112) in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer Patients With KRAS G12C Mutation).
Anisomycin
go.drugbank.com/drugs/DB07374ExperimentalThis drug acts to inhibit bacterial protein and DNA synthesis.
{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid
go.drugbank.com/drugs/DB08098ExperimentalThis compound belongs to the nitrofurans. These are compounds containing a furan ring which bears a nitro group. It targets the protein aldose reductase.
Samelisant
go.drugbank.com/drugs/DB14835InvestigationalSUVN-G3031 is under investigation in clinical trial NCT02342041 (A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects).
PF-05180999
go.drugbank.com/drugs/DB14885InvestigationalPF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999).
KAI-1678
go.drugbank.com/drugs/DB16211InvestigationalKAI-1678 is under investigation in clinical trial NCT01106716 (Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia).